Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine OpTimal Timing for Optimal moNitoring and Side Effects

NCT06749041 is registered in ClinicalTrials.gov with GGZ Noord-Holland-Noord as lead sponsor.

NCT NCT06749041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06749041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine OpTimal Timing for Optimal moNitoring and Side Effects
Lead sponsor
GGZ Noord-Holland-Noord
Phase
Observational
Overall status
Not yet recruiting
Start date
December 23, 2024
Completion date
December 1, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular side effects of clozapine, clozapine and norclozapine plasma level concentrations, constipation due to clozapine, general side effects of clozapine, neutropenia due to clozapine, optimal blood sampling time for clozapine in patients who receive clozapine once and twice daily, symptoms of schizophrenia